ZyVersa Therapeutics’ CEO, Stephen C. Glover to Present at the Stifel 2019 Healthcare Conference
- Wednesday, November 13, 2019, 7:09
- Finance
- Add a comment
WESTON, Fla., Nov. 13, 2019 /PRNewswire/ — ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that Stephen C. Glover, ZyVersa’s Co-Founder,…
About the Author
adminasapcorp has written 41794 stories on this site.